Wij zijn onze website aan het vernieuwen.

Ontdekt u nog een pagina die niet klopt of hebt u een goede suggestie, laat het ons dan weten via webmedia@umcutrecht.nl.

Deze website maakt gebruik van cookies

Deze website toont video’s van o.a. YouTube. Dergelijke partijen plaatsen cookies (third party cookies). Als u deze cookies niet wilt kunt u dat hier aangeven. Lees meer over het cookiebeleid.

prof. dr. G.D. Valk Full Professor

  • Department of Endrocine Oncology

G.D. Valk

Contact

Research Programs

Biography

Endocrinology and endocrine oncology are the main focus of the clinical activities of Gerlof Valk. (Neuro-) endocrine tumors diagnosis, treatment and follow-up, care for patients with Multiple Endocrine Neoplasia (MEN) and the standardization and continuous improvement of the national care for patients with MEN are his specific areas of expertise. Epidemiologic and translational research within the field of MEN related (pancreatic) neuroendocrine tumors is his main research focus including innovative treatment strategies and personalized cancer care.

 

ACADEMIC APPOINTMENTS

2014 – today 

Internist-endocrinologist, professor of endocrinology with emphasis on endocrine tumors, head of section endocrinology, program director endocrinology residency

 

2007 – 2014  

Internist-endocrinologist, vice program director internal medicine residency

 

1997 – 2001  

Senior researcher, Institute for Extramural Medical Research (EMGO Institute), Free University Medical Centre

 

DIPLOMAS AND CERTIFICATION

2007 Certification National Board of Internal Medicine and Endocrinology

2002 MSc Clinical Epidemiology

1997 PhD Thesis: ‘The diagnosing of diabetic polyneuropathy in daily clinical practice’. Free University Medical Centre, Amsterdam

1994 Certification National Board of General Practitioners

1990 MD (cum laude)

 

Side Activities

  • Scientific director of the Parelsnoer Institute (PSI)

    National coordinator of the European Reference Network (ERN) Rare Endocrine Conditions

    Member of the daily board of BijnierNET

    Board member Dutch Society of Endrocrinology

Research Output (130)

Clinical Relevance of Genetic Analysis in Patients With Pituitary Adenomas:A Systematic Review

van den Broek Medard F M, van Nesselrooij Bernadette P M, Verrijn Stuart Annemarie A, van Leeuwaarde Rachel S, Valk Gerlof D 10 dec 2019, In: Frontiers in Endocrinology. 10 16 p.

Prognostic factors and survival in MEN1 patients with gastrinomas:Results from the DutchMEN study group (DMSG)

van Beek Dirk-Jan, Nell Sjoerd, Pieterman Carolina R C, de Herder Wouter W, van de Ven Annenienke C, Dekkers Olaf M, van der Horst-Schrivers Anouk N, Drent Madeleine L, Bisschop Peter H, Havekes Bas, Borel Rinkes Inne H M, Vriens Menno R, Valk Gerlof D 1 nov 2019, In: Journal of Surgical Oncology. 120 , p. 966-975 10 p.

Publisher Correction:Enhancer signatures stratify and predict outcomes of non-functional pancreatic neuroendocrine tumors (Nature Medicine, (2019), 25, 8, (1260-1265), 10.1038/s41591-019-0493-4)

Cejas Paloma, Drier Yotam, Dreijerink Koen M A, Brosens Lodewijk A A, Deshpande Vikram, Epstein Charles B, Conemans Elfi B, Morsink Folkert H M, Graham Mindy K, Valk Gerlof D, Vriens Menno R, Castillo Carlos Fernandez-Del, Ferrone Cristina R, Adar Tomer, Bowden Michaela, Whitton Holly J, Da Silva Annacarolina, Font-Tello Alba, Long Henry W, Gaskell Elizabeth, Shoresh Noam, Heaphy Christopher M, Sicinska Ewa, Kulke Matthew H, Chung Daniel C, Bernstein Bradley E, Shivdasani Ramesh A 9 sep 2019, In: Nature Medicine. 25 , p. 1627 1 p.

Non-islet cell tumour hypoglycaemia in a patient with a well-differentiated gastric neuroendocrine tumour

Versluis Judith, Valk Gerlof, van Rossum Huub, Tesselaar Margot 1 sep 2019, In: BMJ Case Reports. 12

Enhancer signatures stratify and predict outcomes of non-functional pancreatic neuroendocrine tumors

Cejas Paloma, Drier Yotam, Dreijerink Koen M.A., Brosens Lodewijk A.A., Deshpande Vikram, Epstein Charles B., Conemans Elfi B., Morsink Folkert H.M., Graham Mindy K., Valk Gerlof D., Vriens Menno R., Castillo Carlos Fernandez del, Ferrone Cristina R., Adar Tomer, Bowden Michaela, Whitton Holly J., Da Silva Annacarolina, Font-Tello Alba, Long Henry W., Gaskell Elizabeth, Shoresh Noam, Heaphy Christopher M., Sicinska Ewa, Kulke Matthew H., Chung Daniel C., Bernstein Bradley E., Shivdasani Ramesh A. aug 2019, In: Nature Medicine. 25 , p. 1260-1265 6 p.

Molecular prognostic factors in small-intestinal neuroendocrine tumours

Samsom K. G., van Veenendaal L. M., Valk G. D., Vriens M. R., Tesselaar M. E.T., van den Berg J. G. 1 jul 2019, In: Endocrine connections. 8 , p. 906-922 17 p.

Update on phenotypes of MEN1 mutation carriers

Valk G D jun 2019, In: Annales d'endocrinologie. 80 , p. 193-194 2 p.

Natural course of MEN type 2B syndrome; a Dutch single-center cohort

Rijks Ester B G, Valk GD, Verrijn Stuart AA mrt 2019,

The Role of Tumor Functionality on Survival in MEN1-Related Pancreatic Neuroendocrine Tumors: Non-Functioning Pancreatic Neuroendocrine Tumors Versus Insulinomas

Van Beek D. J., Goudet P., Bartsch D. K., Perrier N. D., Brandi M. L., Nilubol N., Brunaud L., Pasternak J. D., Sturgeon C., Rinkes Borel I. H. M., Valk G. D., Vriens M. 2019, In: Neuroendocrinology. 108 , p. 263-263

Using Adult Stem Cell-Derived Organoids to Model Neuroendocrine Neoplasms

Dayton T., Den Hartigh L., McFaline J. L., Van Leeuwaarde R., Valk G. D., Van den Berg J., Tesselaar M., Vriens M., Lopes Chuva de Sousa S. M., Fernandez-Cuesta L., Trapnell C., Clevers H. 2019, In: Neuroendocrinology. 108 , p. 18-18

All Research Output (130)
To top